| Fecha | Trimestre | Sesión | BPA (est → real) | Ingresos (est → reales) |
|---|---|---|---|---|
| 28 oct 2026Próximo | Q3 2026 | Tras el cierre | 2,86 | 1,04 B |
31 ago 2026
TEMPE, Ariz. & SAN JOSE, Calif., August 31, 2026--Align Technology, Inc. ("Align") (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that its Board of Directors has appointed Quentin Blackford, President and Chief Executive Officer of iRhythm Technologies, as a director effective immediate
28 ago 2026
Align Technology (ALGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
27 ago 2026
Despite Align Technology's weak performance relative to the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.
17 ago 2026
Align's $37.5M U.K. VAT liability, new 20% VAT charges and pending appeal add fresh earnings uncertainty amid currency and mix pressures.
13 ago 2026
Align Technology (ALGN) appears undervalued with strong profitability, no debt, and decent growth, fitting the Decent Value screen.
12 ago 2026
Align Technology (ALGN) disclosed late Tuesday that the Jinan Intermediate People's Court in China i
SAN JOSE, Calif. & TEMPE, Ariz., August 12, 2026--Align Technology, Inc. ("Align") (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, today announced that the Jinan Intermediate People's Court in China issued a judgment in favor of Align in a patent infringement action against Angelalign Technology's operating subsidiaries in China ("Angel") (Hong Kong Stock Exchange: 6699.HK).
8 ago 2026
Clear aligner volumes hit record levels amid $37.5 million UK VAT liability.
7 ago 2026
Align Technology delivers record revenue, volume, and operating margins, yet trades near five-year valuation lows. Read more on ALGN stock here.
4 ago 2026
Dental technology company Align Technology (NASDAQ:ALGN) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 4.3% year on year to $1.06 billion. On the other hand, next quarter’s revenue guidance of $1.01 billion was less impressive, coming in 1.3% below analysts’ estimates. Its non-GAAP profit of $2.64 per share was 1.7% above analysts’ consensus estimates.
